Darunavir/Ritonavir (DRV/r) 800mg/100mg Tablets
Darunavir/Ritonavir (DRV/r) 800mg/100mg Tablets are widely used antiretroviral medicines indicated for the management of Human Immunodeficiency Virus (HIV) infection as part of combination antiretroviral therapy (ART). These tablets are commonly supplied for government tenders, hospital procurement programs, NGOs, healthcare institutions, and international pharmaceutical distribution networks.
Detailed Composition
Each film-coated tablet contains:
Darunavir – 800 mg
Ritonavir – 100 mg
Excipients – q.s.
Dosage Form – Film Coated Tablets
Route of Administration – Oral
Therapeutic Category
Antiretroviral Medicine (ARV)
Protease Inhibitor Combination Therapy
HIV/AIDS Management Medicine
Mechanism of Action
Darunavir acts as a protease inhibitor that interferes with viral replication by blocking HIV protease enzymes. Ritonavir acts primarily as a pharmacokinetic enhancer, increasing Darunavir plasma concentration and improving therapeutic effectiveness.
Treatment Applications
Darunavir/Ritonavir 800/100mg Tablets are commonly used for:
✔ HIV-1 infection treatment in adults and eligible adolescents
✔ Combination antiretroviral therapy regimens
✔ Long-term HIV disease management programs
✔ Public healthcare procurement programs
✔ Hospital and specialty infectious disease treatment centers
✔ National HIV control initiatives
✔ International donor-supported HIV treatment programs
Storage Instructions
Store below 30°C
Protect from direct sunlight and moisture
Keep tablets in original packaging until use
Keep out of reach of children
Do not freeze
Maintain proper storage during transportation and export logistics
Packaging Information
Blister Packaging / HDPE Bottle Packaging
Export Grade Packaging Available
Bulk Supply for Institutional Procurement
Custom Labeling Options Available
Global Export Markets
We support international pharmaceutical exports and distribution for buyers, importers, healthcare procurement agencies, and institutional purchasers across:
South Africa, Kenya, Nigeria, Tanzania, Botswana, Mozambique, Zimbabwe, Ethiopia, Lesotho, Philippines, Thailand, Nepal, Myanmar, Brazil, Peru, Colombia, United States, United Kingdom, Germany, Netherlands, Canada, UAE
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Reliable Global Pharmaceutical Exporter
International Supply Chain Support
Bulk Quantity Availability
Export Documentation Assistance
Third-Party Manufacturing Support
Institutional Supply Capability
Regulatory Documentation Support
Order & Enquiry
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
For product availability, export enquiries, bulk procurement, institutional supply, and international distribution partnerships, connect with our export team.
Disclaimer
This information is intended for healthcare awareness and professional reference purposes only. Medicines should be prescribed and used under qualified healthcare supervision and according to local regulatory requirements.
Darunavir/Ritonavir (DRV/r) 800mg/100mg Tablets are widely used antiretroviral medicines indicated for the management of Human Immunodeficiency Virus (HIV) infection as part of combination antiretroviral therapy (ART). These tablets are commonly supplied for government tenders, hospital procurement programs, NGOs, healthcare institutions, and international pharmaceutical distribution networks.
Detailed Composition
Each film-coated tablet contains:
Darunavir – 800 mg
Ritonavir – 100 mg
Excipients – q.s.
Dosage Form – Film Coated Tablets
Route of Administration – Oral
Therapeutic Category
Antiretroviral Medicine (ARV)
Protease Inhibitor Combination Therapy
HIV/AIDS Management Medicine
Mechanism of Action
Darunavir acts as a protease inhibitor that interferes with viral replication by blocking HIV protease enzymes. Ritonavir acts primarily as a pharmacokinetic enhancer, increasing Darunavir plasma concentration and improving therapeutic effectiveness.
Treatment Applications
Darunavir/Ritonavir 800/100mg Tablets are commonly used for:
✔ HIV-1 infection treatment in adults and eligible adolescents
✔ Combination antiretroviral therapy regimens
✔ Long-term HIV disease management programs
✔ Public healthcare procurement programs
✔ Hospital and specialty infectious disease treatment centers
✔ National HIV control initiatives
✔ International donor-supported HIV treatment programs
Storage Instructions
Store below 30°C
Protect from direct sunlight and moisture
Keep tablets in original packaging until use
Keep out of reach of children
Do not freeze
Maintain proper storage during transportation and export logistics
Packaging Information
Blister Packaging / HDPE Bottle Packaging
Export Grade Packaging Available
Bulk Supply for Institutional Procurement
Custom Labeling Options Available
Global Export Markets
We support international pharmaceutical exports and distribution for buyers, importers, healthcare procurement agencies, and institutional purchasers across:
South Africa, Kenya, Nigeria, Tanzania, Botswana, Mozambique, Zimbabwe, Ethiopia, Lesotho, Philippines, Thailand, Nepal, Myanmar, Brazil, Peru, Colombia, United States, United Kingdom, Germany, Netherlands, Canada, UAE
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Reliable Global Pharmaceutical Exporter
International Supply Chain Support
Bulk Quantity Availability
Export Documentation Assistance
Third-Party Manufacturing Support
Institutional Supply Capability
Regulatory Documentation Support
Order & Enquiry
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
For product availability, export enquiries, bulk procurement, institutional supply, and international distribution partnerships, connect with our export team.
Disclaimer
This information is intended for healthcare awareness and professional reference purposes only. Medicines should be prescribed and used under qualified healthcare supervision and according to local regulatory requirements.
Keywords
